“We are extremely excited to add talent to our senior leadership team and we intend to leverage the experience of our new executives and existing leaders to create innovations to further improve health,” said Julie Aker, president and CEO of Concentrics.
Indianapolis, IN (PRWEB) May 22, 2013
Concentrics Research LLC, a privately held business specializing in consumer healthcare research and late-stage clinical research, is pleased to announce that Todd Lehman has joined the company as Chief Operating Officer and Doug Gorr has joined the company as Director of Technology Solutions.
Lehman joins the senior leadership team with extensive experience and a rich background in creative approaches to late stage research, including most recently as director of global late stage research operations for PPD, Inc. Lehman holds a masters in biomedical engineering and a bachelors in chemical engineering from the University of South Florida. Gorr joins Concentrics with a strong background in IT strategy and emerging technologies and he was previously with Nightingale Home Healthcare. Gorr holds a bachelor’s in computer information systems, process management, and operations from the Kelly School of Business at Indiana University. “We are extremely excited to add talent to our senior leadership team and we intend to leverage the experience of our new executives and existing leaders to create innovations to further improve health,” said Julie Aker, president and CEO of Concentrics.
To learn more about Concentrics Research, visit http://www.concentricsresearch.com.
Concentrics Research LLC is a niche late-stage contract research organization that serves the pharmaceutical and device industries. The Company is devoted to client-centered strategies for Rx-to-OTC Switch programs, consumer healthcare research and Phase II-IV clinical trials. Concentrics is a leader in late stage research and research for over-the-counter products. The company works closely with the U.S. Food and Drug Administration, National Institutes of Health, and Centers for Disease Control and Prevention on key industry initiatives and they are involved with pharmaceutical companies in key strategy development and study execution. Concentrics has offices in Indianapolis, Indiana and Parsippany, New Jersey.